This message was sent to ##Email##
|
|
|
|
|
U.S. News & World Report
The U.S. has made undeniable progress in its fight against HIV/AIDS in recent years. From 2010 to 2014, the annual number of new HIV infections in the U.S. declined by 10 percent to 36,700, according to the Centers for Disease Control and Prevention. And since the height of the epidemic in the mid-1980s, new infections have dropped by more than two-thirds.
READ MORE
ALS News Today
Using stem cell treatments to protect motor neurons is not enough to prevent the loss of nerve-muscle connections and disease progression in a mouse model of amyotrophic lateral sclerosis, researchers from Italy found.
The study, published in the journal Stem Cell Research, had exposed mice to repeated brain injections of so-called mesenchymal stem cells, gathered from the umbilical cord.
READ MORE
Streck, Inc.
Learn how customized clinical samples provided by Conversant Bio in Streck Cell-Free DNA BCT® have helped accelerate their cancer research for one of their biotech clients. Conversant Bio is on a mission to develop a liquid biopsy test for early cancer detection in order to increase cancer survivor rates. They were able to buy an additional 48 hours to process samples due to the use of Streck Cell-Free DNA BCT®.
READ MORE
|
|
Outbreak News Today
UT Southwestern Medical Center researchers have identified a chemical that suppresses the lethal form of a parasitic infection caused by roundworms that affects up to 100 million people and usually causes only mild symptoms.
"The approach we used could be applied generally to any nematode parasite, not just this one type," said Dr. David Mangelsdorf, chair of pharmacology, an investigator in the prestigious Howard Hughes Medical Institute, and one of three corresponding authors of the study published in the Proceedings of the National Academy of Sciences.
READ MORE
Medical News Today
Adding aspirin to a particular cancer medication increases its effectiveness against some cancers. These latest findings offer hope for individuals with certain difficult-to-treat cancers.
READ MORE
|
Promoted by
|
|
|
|
 |
University of North Carolina School of Medicine via Infection Control Today
Scientists at the University of North Carolina School of Medicine have found that a bacterium can become much more or less susceptible to an antibiotic depending on the specific bacterial community in its midst. The scientists found specifically that the bacterium Pseudomonas aeruginosa can produce specific molecular factors that dramatically increase or decrease an antibiotic's ability to kill Staphylococcus aureus, another bacterium that often co-infects with P. aeruginosa.
READ MORE
 |
|
Performance, reporting, and QA recommendations for identification of cultured microorganisms take the guesswork out of introducing MALDI-TOF into your laboratory. CLSI’s M58 includes recommendations for end-user verification and workflow integration, along with best practices for quality and safety.
Visit clsi.org/m58/ for more information.
|
|
HealthDay News
There's bad news about this year's flu vaccine.
The most common type of flu being seen in the United States is influenza A H3N2, the same severe strain that dominated last flu season.
READ MORE
|
Promoted by
|
|
|
|
 |
University of Warwick via Lab Manager
Tuberculosis, and other life-threatening microbial diseases, could be more effectively tackled with future drugs, thanks to new research into an old antibiotic by the University of Warwick and The Francis Crick Institute.
Led by professor David Roper at Warwick's School of Life Sciences and Dr. Luiz Pedro Carvalho from The Francis Crick Institute, a paper published in Nature Communications reveals a deeper understanding of how the antibiotic D-cycloserine uniquely works at a molecular level.
READ MORE
|
|
New Atlas
Stem cells have incredible potential for regenerative medicine, but getting hold of them in large enough numbers can be tricky. Amniotic fluid may be a plentiful source, and now scientists from Lund University in Sweden have developed a method and device that can collect the fluid during delivery of a baby by caesarean section to safely harvest large amounts of stem cells.
READ MORE
 |
|
The LIAISON® Treponema assay is your solution for automating syphilis testing. Improve sensitivity and specificity over RPR screening using our fully-automated LIAISON® XL platform. The LIAISON® Treponema assay detects both IgG and IgM antibody response to T. pallidum infections. Visit www.diasorin.com for more information.
|
|
Ecole Polytechnique Fédérale de Lausanne via ScienceDaily
Alzheimer's disease is the most common form of dementia and neurodegeneration worldwide. A major hallmark of the disease is the accumulation of toxic plaques in the brain, formed by the abnormal aggregation of a protein called beta-amyloid inside neurons.
READ MORE
|
This webinar series provides an introduction for laboratory technologists. Participants develop the knowledge and skills necessary to perform and interpret antimicrobial susceptibility and report results.
|
|
|
|
SeraSub® is a synthetic serum for use as a component in preparing standards and controls for in-vitro diagnostic tests. Learn more
|
|
|
|
DARK Daily
Determining where breast cancer ends and healthy tissue begins is a critical part of breast cancer surgery. Surgeons are used to working closely during surgery with anatomic pathologists who generate pathology reports that specify the surgical or tumor margin, an area of healthy tissue surrounding a tumor that also must be excised to ensure none of the tumor is left behind. This helps prevent the need for follow-up surgeries and involves quick work on the part of medical laboratories.
READ MORE
|
Missed last week's issue? See which articles your colleagues read most.
|
|
Don't be left behind. Click here to see what else you missed.
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
